Vaccine Conjugate and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Vaccine Conjugate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Conjugate Overall Market Size
2.1 Global Vaccine Conjugate Market Size: 2023 VS 2030
2.2 Global Vaccine Conjugate Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Vaccine Conjugate Sales: 2019-2030
3 Company Landscape
3.1 Top Vaccine Conjugate Players in Global Market
3.2 Top Global Vaccine Conjugate Companies Ranked by Revenue
3.3 Global Vaccine Conjugate Revenue by Companies
3.4 Global Vaccine Conjugate Sales by Companies
3.5 Global Vaccine Conjugate Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Vaccine Conjugate Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Vaccine Conjugate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine Conjugate Players in Global Market
3.8.1 List of Global Tier 1 Vaccine Conjugate Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccine Conjugate Market Size Markets, 2023 & 2030
4.1.2 Hib Vaccine
4.1.3 Meningococcal Vaccine
4.1.4 Pneumococcal Vaccine
4.1.5 Others
4.2 By Type - Global Vaccine Conjugate Revenue & Forecasts
4.2.1 By Type - Global Vaccine Conjugate Revenue, 2019-2024
4.2.2 By Type - Global Vaccine Conjugate Revenue, 2025-2030
4.2.3 By Type - Global Vaccine Conjugate Revenue Market Share, 2019-2030
4.3 By Type - Global Vaccine Conjugate Sales & Forecasts
4.3.1 By Type - Global Vaccine Conjugate Sales, 2019-2024
4.3.2 By Type - Global Vaccine Conjugate Sales, 2025-2030
4.3.3 By Type - Global Vaccine Conjugate Sales Market Share, 2019-2030
4.4 By Type - Global Vaccine Conjugate Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccine Conjugate Market Size, 2023 & 2030
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Vaccine Conjugate Revenue & Forecasts
5.2.1 By Application - Global Vaccine Conjugate Revenue, 2019-2024
5.2.2 By Application - Global Vaccine Conjugate Revenue, 2025-2030
5.2.3 By Application - Global Vaccine Conjugate Revenue Market Share, 2019-2030
5.3 By Application - Global Vaccine Conjugate Sales & Forecasts
5.3.1 By Application - Global Vaccine Conjugate Sales, 2019-2024
5.3.2 By Application - Global Vaccine Conjugate Sales, 2025-2030
5.3.3 By Application - Global Vaccine Conjugate Sales Market Share, 2019-2030
5.4 By Application - Global Vaccine Conjugate Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Vaccine Conjugate Market Size, 2023 & 2030
6.2 By Region - Global Vaccine Conjugate Revenue & Forecasts
6.2.1 By Region - Global Vaccine Conjugate Revenue, 2019-2024
6.2.2 By Region - Global Vaccine Conjugate Revenue, 2025-2030
6.2.3 By Region - Global Vaccine Conjugate Revenue Market Share, 2019-2030
6.3 By Region - Global Vaccine Conjugate Sales & Forecasts
6.3.1 By Region - Global Vaccine Conjugate Sales, 2019-2024
6.3.2 By Region - Global Vaccine Conjugate Sales, 2025-2030
6.3.3 By Region - Global Vaccine Conjugate Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Vaccine Conjugate Revenue, 2019-2030
6.4.2 By Country - North America Vaccine Conjugate Sales, 2019-2030
6.4.3 US Vaccine Conjugate Market Size, 2019-2030
6.4.4 Canada Vaccine Conjugate Market Size, 2019-2030
6.4.5 Mexico Vaccine Conjugate Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Vaccine Conjugate Revenue, 2019-2030
6.5.2 By Country - Europe Vaccine Conjugate Sales, 2019-2030
6.5.3 Germany Vaccine Conjugate Market Size, 2019-2030
6.5.4 France Vaccine Conjugate Market Size, 2019-2030
6.5.5 U.K. Vaccine Conjugate Market Size, 2019-2030
6.5.6 Italy Vaccine Conjugate Market Size, 2019-2030
6.5.7 Russia Vaccine Conjugate Market Size, 2019-2030
6.5.8 Nordic Countries Vaccine Conjugate Market Size, 2019-2030
6.5.9 Benelux Vaccine Conjugate Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Vaccine Conjugate Revenue, 2019-2030
6.6.2 By Region - Asia Vaccine Conjugate Sales, 2019-2030
6.6.3 China Vaccine Conjugate Market Size, 2019-2030
6.6.4 Japan Vaccine Conjugate Market Size, 2019-2030
6.6.5 South Korea Vaccine Conjugate Market Size, 2019-2030
6.6.6 Southeast Asia Vaccine Conjugate Market Size, 2019-2030
6.6.7 India Vaccine Conjugate Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Vaccine Conjugate Revenue, 2019-2030
6.7.2 By Country - South America Vaccine Conjugate Sales, 2019-2030
6.7.3 Brazil Vaccine Conjugate Market Size, 2019-2030
6.7.4 Argentina Vaccine Conjugate Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccine Conjugate Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Vaccine Conjugate Sales, 2019-2030
6.8.3 Turkey Vaccine Conjugate Market Size, 2019-2030
6.8.4 Israel Vaccine Conjugate Market Size, 2019-2030
6.8.5 Saudi Arabia Vaccine Conjugate Market Size, 2019-2030
6.8.6 UAE Vaccine Conjugate Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Vaccine Conjugate Major Product Offerings
7.1.4 Pfizer Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Vaccine Conjugate Major Product Offerings
7.2.4 GSK Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Vaccine Conjugate Major Product Offerings
7.3.4 Sanofi Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.3.5 Sanofi Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Vaccine Conjugate Major Product Offerings
7.4.4 Merck Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Company Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Vaccine Conjugate Major Product Offerings
7.5.4 Walvax Biotechnology Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.5.5 Walvax Biotechnology Key News & Latest Developments
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Summary
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Major Product Offerings
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
7.7 Bharat Biotech
7.7.1 Bharat Biotech Company Summary
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Vaccine Conjugate Major Product Offerings
7.7.4 Bharat Biotech Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.7.5 Bharat Biotech Key News & Latest Developments
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Company Summary
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Vaccine Conjugate Major Product Offerings
7.8.4 Zhifei Biologic Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.8.5 Zhifei Biologic Key News & Latest Developments
7.9 Chengdu Olymvax Biopharmaceuticals
7.9.1 Chengdu Olymvax Biopharmaceuticals Company Summary
7.9.2 Chengdu Olymvax Biopharmaceuticals Business Overview
7.9.3 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Major Product Offerings
7.9.4 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.9.5 Chengdu Olymvax Biopharmaceuticals Key News & Latest Developments
7.10 Beijing Minhai Biotechnology
7.10.1 Beijing Minhai Biotechnology Company Summary
7.10.2 Beijing Minhai Biotechnology Business Overview
7.10.3 Beijing Minhai Biotechnology Vaccine Conjugate Major Product Offerings
7.10.4 Beijing Minhai Biotechnology Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.10.5 Beijing Minhai Biotechnology Key News & Latest Developments
7.11 CanSinoBIO
7.11.1 CanSinoBIO Company Summary
7.11.2 CanSinoBIO Business Overview
7.11.3 CanSinoBIO Vaccine Conjugate Major Product Offerings
7.11.4 CanSinoBIO Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.11.5 CanSinoBIO Key News & Latest Developments
7.12 Beijing Xiangrui Biological Products
7.12.1 Beijing Xiangrui Biological Products Company Summary
7.12.2 Beijing Xiangrui Biological Products Business Overview
7.12.3 Beijing Xiangrui Biological Products Vaccine Conjugate Major Product Offerings
7.12.4 Beijing Xiangrui Biological Products Vaccine Conjugate Sales and Revenue in Global (2019-2024)
7.12.5 Beijing Xiangrui Biological Products Key News & Latest Developments
8 Global Vaccine Conjugate Production Capacity, Analysis
8.1 Global Vaccine Conjugate Production Capacity, 2019-2030
8.2 Vaccine Conjugate Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine Conjugate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine Conjugate Supply Chain Analysis
10.1 Vaccine Conjugate Industry Value Chain
10.2 Vaccine Conjugate Upstream Market
10.3 Vaccine Conjugate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine Conjugate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Vaccine Conjugate in Global Market
Table 2. Top Vaccine Conjugate Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Vaccine Conjugate Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Vaccine Conjugate Revenue Share by Companies, 2019-2024
Table 5. Global Vaccine Conjugate Sales by Companies, (K Doses), 2019-2024
Table 6. Global Vaccine Conjugate Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Vaccine Conjugate Price (2019-2024) & (US$/Dose)
Table 8. Global Manufacturers Vaccine Conjugate Product Type
Table 9. List of Global Tier 1 Vaccine Conjugate Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Vaccine Conjugate Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Vaccine Conjugate Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Vaccine Conjugate Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Vaccine Conjugate Sales (K Doses), 2019-2024
Table 15. By Type - Global Vaccine Conjugate Sales (K Doses), 2025-2030
Table 16. By Application ? Global Vaccine Conjugate Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Vaccine Conjugate Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Vaccine Conjugate Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Vaccine Conjugate Sales (K Doses), 2019-2024
Table 20. By Application - Global Vaccine Conjugate Sales (K Doses), 2025-2030
Table 21. By Region ? Global Vaccine Conjugate Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Vaccine Conjugate Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Vaccine Conjugate Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Vaccine Conjugate Sales (K Doses), 2019-2024
Table 25. By Region - Global Vaccine Conjugate Sales (K Doses), 2025-2030
Table 26. By Country - North America Vaccine Conjugate Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Vaccine Conjugate Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Vaccine Conjugate Sales, (K Doses), 2019-2024
Table 29. By Country - North America Vaccine Conjugate Sales, (K Doses), 2025-2030
Table 30. By Country - Europe Vaccine Conjugate Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Vaccine Conjugate Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Vaccine Conjugate Sales, (K Doses), 2019-2024
Table 33. By Country - Europe Vaccine Conjugate Sales, (K Doses), 2025-2030
Table 34. By Region - Asia Vaccine Conjugate Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Vaccine Conjugate Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Vaccine Conjugate Sales, (K Doses), 2019-2024
Table 37. By Region - Asia Vaccine Conjugate Sales, (K Doses), 2025-2030
Table 38. By Country - South America Vaccine Conjugate Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Vaccine Conjugate Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Vaccine Conjugate Sales, (K Doses), 2019-2024
Table 41. By Country - South America Vaccine Conjugate Sales, (K Doses), 2025-2030
Table 42. By Country - Middle East & Africa Vaccine Conjugate Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Vaccine Conjugate Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Vaccine Conjugate Sales, (K Doses), 2019-2024
Table 45. By Country - Middle East & Africa Vaccine Conjugate Sales, (K Doses), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Vaccine Conjugate Product Offerings
Table 48. Pfizer Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Vaccine Conjugate Product Offerings
Table 52. GSK Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Vaccine Conjugate Product Offerings
Table 56. Sanofi Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 57. Sanofi Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Vaccine Conjugate Product Offerings
Table 60. Merck Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Walvax Biotechnology Company Summary
Table 63. Walvax Biotechnology Vaccine Conjugate Product Offerings
Table 64. Walvax Biotechnology Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 65. Walvax Biotechnology Key News & Latest Developments
Table 66. Royal (Wuxi) Bio-Pharmaceutical Company Summary
Table 67. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product Offerings
Table 68. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 69. Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
Table 70. Bharat Biotech Company Summary
Table 71. Bharat Biotech Vaccine Conjugate Product Offerings
Table 72. Bharat Biotech Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 73. Bharat Biotech Key News & Latest Developments
Table 74. Zhifei Biologic Company Summary
Table 75. Zhifei Biologic Vaccine Conjugate Product Offerings
Table 76. Zhifei Biologic Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 77. Zhifei Biologic Key News & Latest Developments
Table 78. Chengdu Olymvax Biopharmaceuticals Company Summary
Table 79. Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Product Offerings
Table 80. Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 81. Chengdu Olymvax Biopharmaceuticals Key News & Latest Developments
Table 82. Beijing Minhai Biotechnology Company Summary
Table 83. Beijing Minhai Biotechnology Vaccine Conjugate Product Offerings
Table 84. Beijing Minhai Biotechnology Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 85. Beijing Minhai Biotechnology Key News & Latest Developments
Table 86. CanSinoBIO Company Summary
Table 87. CanSinoBIO Vaccine Conjugate Product Offerings
Table 88. CanSinoBIO Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 89. CanSinoBIO Key News & Latest Developments
Table 90. Beijing Xiangrui Biological Products Company Summary
Table 91. Beijing Xiangrui Biological Products Vaccine Conjugate Product Offerings
Table 92. Beijing Xiangrui Biological Products Vaccine Conjugate Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2019-2024)
Table 93. Beijing Xiangrui Biological Products Key News & Latest Developments
Table 94. Vaccine Conjugate Production Capacity (K Doses) of Key Manufacturers in Global Market, 2022-2024 (K Doses)
Table 95. Global Vaccine Conjugate Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Vaccine Conjugate Production by Region, 2019-2024 (K Doses)
Table 97. Global Vaccine Conjugate Production by Region, 2025-2030 (K Doses)
Table 98. Vaccine Conjugate Market Opportunities & Trends in Global Market
Table 99. Vaccine Conjugate Market Drivers in Global Market
Table 100. Vaccine Conjugate Market Restraints in Global Market
Table 101. Vaccine Conjugate Raw Materials
Table 102. Vaccine Conjugate Raw Materials Suppliers in Global Market
Table 103. Typical Vaccine Conjugate Downstream
Table 104. Vaccine Conjugate Downstream Clients in Global Market
Table 105. Vaccine Conjugate Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vaccine Conjugate Segment by Type in 2023
Figure 2. Vaccine Conjugate Segment by Application in 2023
Figure 3. Global Vaccine Conjugate Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Vaccine Conjugate Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Vaccine Conjugate Revenue, 2019-2030 (US$, Mn)
Figure 7. Vaccine Conjugate Sales in Global Market: 2019-2030 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Vaccine Conjugate Revenue in 2023
Figure 9. By Type - Global Vaccine Conjugate Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 11. By Type - Global Vaccine Conjugate Sales Market Share, 2019-2030
Figure 12. By Type - Global Vaccine Conjugate Price (US$/Dose), 2019-2030
Figure 13. By Application - Global Vaccine Conjugate Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 15. By Application - Global Vaccine Conjugate Sales Market Share, 2019-2030
Figure 16. By Application - Global Vaccine Conjugate Price (US$/Dose), 2019-2030
Figure 17. By Region - Global Vaccine Conjugate Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Vaccine Conjugate Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 20. By Region - Global Vaccine Conjugate Sales Market Share, 2019-2030
Figure 21. By Country - North America Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 22. By Country - North America Vaccine Conjugate Sales Market Share, 2019-2030
Figure 23. US Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Vaccine Conjugate Sales Market Share, 2019-2030
Figure 28. Germany Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 29. France Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Vaccine Conjugate Sales Market Share, 2019-2030
Figure 37. China Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 41. India Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 43. By Country - South America Vaccine Conjugate Sales Market Share, 2019-2030
Figure 44. Brazil Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Vaccine Conjugate Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Vaccine Conjugate Sales Market Share, 2019-2030
Figure 48. Turkey Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Vaccine Conjugate Revenue, (US$, Mn), 2019-2030
Figure 52. Global Vaccine Conjugate Production Capacity (K Doses), 2019-2030
Figure 53. The Percentage of Production Vaccine Conjugate by Region, 2023 VS 2030
Figure 54. Vaccine Conjugate Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
